Table 3 Postoperative outcomes

Early postoperative superior vena cava pressure (mmHg) (n = 153)

18 (15–20)

Inhaled nitric oxide (n = 257)

29 (11.28%)

Sildenafil (n = 256)

54 (21.09%)

Postoperative saturation (%) (n = 248)

89 (85–93)

Delayed sternal closure (n = 257)

14 (5.45%)

Early postoperative intervention (n = 169)

26 (15.38%)

Chylothorax (n = 253)

32 (12.65%)

Phrenic nerve palsy (n = 255)

26 (10.20%)

Mechanical ventilation (hours) (n = 246)

10 (6–23)

Chest tube duration (days) (n = 230)

6 (4–8)

ICU stay (days) (n = 170)

5 (3–8)

Hospital stay (days) (n = 253)

12 (9–19)

Fontan completion (n = 257)

98 (38.13%)

Hospital mortality

10 (3.86%)

Interstage mortality

4 (1.54%)

Mortality after Fontan

5 (1.93%)

Pre-Fontan data

 Pulmonary artery diameter (mm) (n = 86)

7.55 (6.3–8.8)

 Left pulmonary artery cross sectional area (mm2) (n = 86)

44.77 (31.17–60.82)

 Nakata index (mm2/m2) (n = 86)

173 (130.92–225.34)

 Indexed right pulmonary artery diameter (mm/m2) (n = 86)

14.19 (12.14–16.41)

 Indexed left pulmonary artery diameter (mm/m2) (n = 86)

11.88 (10–13.73)

 Right/left pulmonary artery diameter (n = 86)

1.17 (1.03–1.38)